2nd Quarter - Report

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Firm
Client
Income
—
Expenses
$1,250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
GREGG HAIFLEY —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
CAROLINE POWERS —
RICHARD WOODRUFF —

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); State, Dept of (DOS); U.S. Agency for International Development (USAID); Labor, Dept of (DOL); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); White House Office

Health Issues HCR

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opiod prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
MATTHEW CASTON New —
LAUREN COATOAM —
GREGG HAIFLEY —
GRETA JOHNSON —
KATRINA KAMM —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MAGGIE OSBORNE —
MATTHEW PHELAN —
CAROLINE POWERS —
DAVID PUGACH —
EMILY WHITE —
BLAKE WINDHAM —
RICHARD WOODRUFF —

Contacted: Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); White House Office; State, Dept of (DOS); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Labor, Dept of (DOL)

Bills named: S. 1014 (114th), S. 1566 (114th), H.R. 3381 (114th), S. 2217 (114th), H.R. 2017 (114th), H.R. 2846 (114th), S. 2748 (114th), S. 2787 (114th), H.R. 716 (114th), S. 370 (114th), H.R. 5475 (114th), S. 540 (114th), S. 1170 (114th), S. 1883 (114th), H.R. 644 (114th), H.R. 2739 (114th), S. 2943 (114th), H.R. 1608 (114th), S. 524 (114th), S. 705 (114th), H.R. 953 (114th), H.R. 2191 (114th), H.R. 3119 (114th), S. 3136 (114th), H.R. 5003 (114th)

Medicare/Medicaid MMM

Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
KATRINA KAMM —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MATTHEW PHELAN —
CAROLINE POWERS —
EMILY WHITE —
BLAKE WINDHAM —
RICHARD WOODRUFF —

Contacted: White House Office; State, Dept of (DOS); U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); SENATE; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1220 (114th), H.R. 1190 (114th), S. 624 (114th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on H.R.2577, FY17 THUD - MIL CON Appropriations legislation; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H. Con. Res. 25, the FY17 budget resolution, H.R.5054, the House FY17 Agriculture Appropriations legislation and S.2956, the Senate Companion Appropriations bill; S.3040, the Senate FY17 Labor, Health and Human Services Appropriations legislation and the un-numbered House Companion Appropriations bill; issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation; and the House-passed 21st Century Cures legislation. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation and the House Companion draft Appropriations bill.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON —
OKEYSHA BROOKS-COLEY —
MATTHEW CASTON New —
LAUREN COATOAM —
GREGG HAIFLEY —
PAUL HOLMES New —
GRETA JOHNSON —
KATRINA KAMM —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MAGGIE OSBORNE —
MATTHEW PHELAN —
CAROLINE POWERS —
DAVID PUGACH —
EMILY WHITE —
BLAKE WINDHAM —
RICHARD WOODRUFF —

Contacted: U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); White House Office; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA)

Bills named: S. 3117 (114th), S. 2956 (114th), H.R. 5054 (114th), H.Con.Res. 25 (114th), S. 3040 (114th), H.R. 2577 (114th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
GRETA JOHNSON —
KATRINA KAMM —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MATTHEW PHELAN —
CAROLINE POWERS —
DAVID PUGACH —
RICHARD WOODRUFF —

Contacted: Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); State, Dept of (DOS); White House Office; U.S. Agency for International Development (USAID)

Bills named: H.R. 1749 (114th), S. 1129 (114th), S. 450 (114th), S. 430 (114th), H.R. 478 (114th), H.R. 3042 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.